mitomycin has been researched along with Bilateral Wilms Tumor in 3 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KOOP, CE | 1 |
Imray, FP | 1 |
Smith, PJ | 1 |
Relf, W | 1 |
Kidson, C | 1 |
Crawfurd, MD | 1 |
3 other studies available for mitomycin and Bilateral Wilms Tumor
Article | Year |
---|---|
CURRENT MANAGEMENT OF NEPHROBLASTOMA AND NEUROBLASTOMA.
Topics: Antineoplastic Agents; Child; Dactinomycin; Fluorouracil; Infant; Infant, Newborn; Kidney Neoplasms; | 1964 |
Wilms' tumour: association with cellular sensitivity to mitomycin C in patients and first-degree relatives.
Topics: Adult; Antibiotics, Antineoplastic; Cell Line; Cell Survival; Child; Chromosome Aberrations; Disease | 1984 |
Mutant genes in Wilms' tumour.
Topics: Chromosome Aberrations; Chromosomes, Human, 6-12 and X; Female; Humans; Kidney Neoplasms; Male; Mito | 1984 |